Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy.

× No keyword cloud information.

13 in total

1. The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells.

Authors: S Koochekpour; M Jeffers; P H Wang; C Gong; G A Taylor; L M Roessler; R Stearman; J R Vasselli; W G Stetler-Stevenson; W G Kaelin; W M Linehan; R D Klausner; J R Gnarra; G F Vande Woude
Journal: Mol Cell Biol Date: 1999-09 Impact factor: 4.272

Review 2. Cytokine and endocrine signaling in prostate cancer.

Authors: J Puente Vazquez; E Grande Pulido; L M Anton Aparicio
Journal: Med Oncol Date: 2011-08-20 Impact factor: 3.064

3. Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic lesions.

Authors: I Leav; F B Merk; K F Lee; M Loda; M Mandoki; J E McNeal; S M Ho
Journal: Am J Pathol Date: 1999-03 Impact factor: 4.307

4. Dysplasia of human prostate CD133(hi) sub-population in NOD-SCIDS is blocked by c-myc anti-sense.

Authors: S M Goodyear; M D Amatangelo; M E Stearns
Journal: Prostate Date: 2009-05-15 Impact factor: 4.104

5. Effects of Transdermal Testosterone Gel or an Aromatase Inhibitor on Prostate Volume in Older Men.

Authors: Jenny Pena Dias; Denise Melvin; Michelle Shardell; Luigi Ferrucci; Chee W Chia; Mohsen Gharib; Josephine M Egan; Shehzad Basaria
Journal: J Clin Endocrinol Metab Date: 2016-03-07 Impact factor: 5.958

Review 6. Antiestrogens and selective estrogen receptor modulators reduce prostate cancer risk.

Authors: Mitchell S Steiner; Sharan Raghow
Journal: World J Urol Date: 2003-02-14 Impact factor: 4.226

7. PTHrP contributes to the anti-proliferative and integrin alpha6beta4-regulating effects of 1,25-dihydroxyvitamin D(3).

Authors: Xiaoli Shen; Ramanjaneya V R Mula; Jing Li; Nancy L Weigel; Miriam Falzon
Journal: Steroids Date: 2007-08-15 Impact factor: 2.668

8. Parathyroid hormone-related protein regulates cell survival pathways via integrin alpha6beta4-mediated activation of phosphatidylinositol 3-kinase/Akt signaling.

Authors: Vandanajay Bhatia; Ramanjaneya V Mula; Nancy L Weigel; Miriam Falzon
Journal: Mol Cancer Res Date: 2009-07-07 Impact factor: 5.852

9. Neoadjuvant hormone therapy before radical prostatectomy does not improve disease-specific survival.

Authors: M S Steiner
Journal: Curr Urol Rep Date: 2000-05 Impact factor: 2.862

10. Qianliening capsule treats benign prostatic hyperplasia via suppression of the EGF/STAT3 signaling pathway.

Authors: Jiumao Lin; Jianheng Zhou; Wei Xu; Xiaoyong Zhong; Zhenfeng Hong; Jun Peng
Journal: Exp Ther Med Date: 2013-03-15 Impact factor: 2.447